1-1 of 1
Authors: Ben Harrison
Sort by
Journal Article
5 A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of HC-7366 in Combination with Belzutifan (WELIREGTM) in Patients with Advanced or Metastatic Renal Cell Carcinoma, NCT06234605
Rana R McKay and others
The Oncologist, Volume 29, Issue Supplement_1, September 2024, Page S13, https://doi.org/10.1093/oncolo/oyae181.019
Published: 05 August 2024
Advertisement
Advertisement